Establishment of Health Clinics As Mass Screening and Referral Systems for Chronic Non-communicable Diseases in Primary Health Care

Overview

Journal Int J Prev Med

Date 2012 Mar 27

PMID 22448310

Citations 2

Authors

Kamal Heidari

Sayyed Ali Sajjadi

Rezvaneh Hadian

Somayeh Hadi

Ramesh Hosseinkhani

Soudabeh Amini

Zahra Kiani

Ali Ajami

Reza Fadaei

Anahita Shahriari

Kasra Keramatian

Affiliations

Soon will be listed here.

Abstract

Background: This study aimed to establish a comprehensive screening and referral system for chronic non-communicable diseases (CNCD) in the routine primary health care, and to determine the prevalence of diabetes, pre-diabetes, metabolic syndrome, and dyslipidemia in adult population invited by public announcement to the Health clinics in Isfahan, Iran.

Methods: This survey was conducted from March 2010, and the current paper presents data obtained until November 2011. To provide health services for prevention and control of CNCDs, with priority of type2 diabetes mellitus, Health clinics were established in different parts of Isfahan city with a population of approximately 2,100,000 in Iran. The general populations aged 30 years and above were invited to the Health clinics by public announcement.

Results: A total of 198972 participants were screened. The mean age of participants was 47.8 years (48.5 men, 47.3 women), with a range of 1 to 95 years old and standard deviation of 12.3 years (12.7 men, 12.1 women). Overall, 22% of participants had impaired fasting glucose, 25% had hypercholesterolemia, 31% had hypertriglyceridemia, and 20% had metabolic syndrome.

Conclusion: The high prevalence of dysglycemia and diabetes in our survey may serve as confirmatory evidence about the importance of mass screening and early diagnosis of CNCDs' risk factors. Our model of establishing Health clinics, as a comprehensive referral system in the routine primary health care can be adopted by Middle Eastern countries, where CNCDs notably diabetes are an emerging health problem.

Citing Articles

Patients' attendance patterns to different healthcare settings and perceptions of stakeholders regarding screening for chronic, non-communicable diseases in high street dental practices and community pharmacy: a cross-sectional study.

Yonel Z, Sharma P, Yahyouche A, Jalal Z, Dietrich T, Chapple I BMJ Open. 2018; 8(11):e024503.

PMID: 30391921 PMC: 6231598. DOI: 10.1136/bmjopen-2018-024503.

Effect of a Probiotic and Metformin on Liver Aminotransferases in Non-alcoholic Steatohepatitis: A Double Blind Randomized Clinical Trial.

Shavakhi A, Minakari M, Firouzian H, Assali R, Hekmatdoost A, Ferns G Int J Prev Med. 2013; 4(5):531-7.

PMID: 23930163 PMC: 3733183.

References

Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. DOI: 10.2337/diacare.27.5.1047. View

Cheng K, Chen Y, Lai S . Prevalence of dyslipidemia in patients receiving health checkups: a hospital-based study. Cholesterol. 2011; 2011:314234. PMC: 3205721. DOI: 10.1155/2011/314234. View

Delavari A, Forouzanfar M, Alikhani S, Sharifian A, Kelishadi R . First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care. 2009; 32(6):1092-7. PMC: 2681035. DOI: 10.2337/dc08-1800. View

Esteghamati A, Gouya M, Abbasi M, Delavari A, Alikhani S, Alaedini F . Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care. 2007; 31(1):96-8. DOI: 10.2337/dc07-0959. View

Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh M, Safarian M, Esmaeili H, Parizadeh S . Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore Med J. 2008; 49(7):571-6. View

Cowie C, Rust K, Byrd-Holt D, Eberhardt M, Flegal K, Engelgau M . Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care. 2006; 29(6):1263-8. DOI: 10.2337/dc06-0062. View

. Standards of medical care in diabetes--2008. Diabetes Care. 2008; 31 Suppl 1:S12-54. DOI: 10.2337/dc08-S012. View

Azizi F, Guoya M, Vazirian P, Dolatshati P, Habbibian S . Screening for type 2 diabetes in the Iranian national programme: a preliminary report. East Mediterr Health J. 2006; 9(5-6):1122-7. View

Yang S, Dou K, Song W . Prevalence of diabetes among men and women in China. N Engl J Med. 2010; 362(25):2425-6. View

10.

Zimmet P . Epidemiology of diabetes mellitus and associated cardiovascular risk factors: focus on human immunodeficiency virus and psychiatric disorders. Am J Med. 2005; 118 Suppl 2:3S-8S. DOI: 10.1016/j.amjmed.2005.01.044. View

11.

Dunstan D, Zimmet P, Welborn T, de Courten M, Cameron A, Sicree R . The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care. 2002; 25(5):829-34. DOI: 10.2337/diacare.25.5.829. View

12.

Knowler W, Barrett-Connor E, Fowler S, Hamman R, Lachin J, Walker E . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346(6):393-403. PMC: 1370926. DOI: 10.1056/NEJMoa012512. View

13.

Mayer-Davis E, DAgostino Jr R, Karter A, Haffner S, Rewers M, Saad M . Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. JAMA. 1998; 279(9):669-74. DOI: 10.1001/jama.279.9.669. View

14.

Thompson T, Engelgau M, Hegazy M, Ali M, Sous E, Badran A . The onset of NIDDM and its relationship to clinical diagnosis in Egyptian adults. Diabet Med. 1996; 13(4):337-40. DOI: 10.1002/(SICI)1096-9136(199604)13:4<337::AID-DIA71>3.0.CO;2-A. View

15.

Velazquez Monroy O, Rosas Peralta M, Esqueda A, Pastelin Hernandez G, Attie F, Tapia Conyer R . [Arterial hypertension in Mexico: results of the National Health Survey 2000]. Arch Cardiol Mex. 2002; 72(1):71-84. View

16.

Kahn R, Alperin P, Eddy D, Borch-Johnsen K, Buse J, Feigelman J . Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis. Lancet. 2010; 375(9723):1365-74. DOI: 10.1016/S0140-6736(09)62162-0. View

17.

. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25):3143-421. View

18.

Passos V, Barreto S, Diniz L, Lima-Costa M . Type 2 diabetes: prevalence and associated factors in a Brazilian community--the Bambuí health and aging study. Sao Paulo Med J. 2005; 123(2):66-71. PMC: 11052420. DOI: 10.1590/s1516-31802005000200007. View

19.

Sadeghi M, Roohafza H, Shirani S, Poormoghadas M, Kelishadi R, Baghaii A . Diabetes and associated cardiovascular risk factors in Iran: the Isfahan Healthy Heart Programme. Ann Acad Med Singap. 2007; 36(3):175-80. View

20.

Grundy S, Cleeman J, Daniels S, Donato K, Eckel R, Franklin B . Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev. 2006; 13(6):322-7. View